Mary Blandford, Frederic G. Barr, James C. Lynch, R. Lor Randall, Stephen J. Qualman, Charles Keller. “Rhabdomyosarcomas Utilize Developmental Myogenic Growth Factors for Disease Advantage,” Pediatric Blood & Cancer, 2006 Mar; 46(3):329-38 [PubMed UID 16261596]